Susan G. Kim
Net Worth
Last updated:
What is Susan G. Kim net worth?
The estimated net worth of Ms. Susan G. Kim is at least $2,892,474 as of 4 Mar 2024. She owns shares worth $946,665 as insider, has earned $990,329 from insider trading and has received compensation worth at least $955,480 in Pacific Biosciences of California, Inc..
What is the salary of Susan G. Kim?
Ms. Susan G. Kim salary is $238,870 per year as Chief Financial Officer in Pacific Biosciences of California, Inc..
How old is Susan G. Kim?
Ms. Susan G. Kim is 48 years old, born in 1977.
What stocks does Susan G. Kim currently own?
As insider, Ms. Susan G. Kim owns shares in one company:
| Company | Title | Shares | Price per share | Total value |
|---|---|---|---|---|
| Pacific Biosciences of California, Inc. (PACB) | Chief Financial Officer | 712,260 | $1.33 | $946,665 |
What does Pacific Biosciences of California, Inc. do?
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
Susan G. Kim insider trading
Pacific Biosciences of California, Inc.
Ms. Susan G. Kim has made 9 insider trades between 2021-2024, according to the Form 4 filled with the SEC. Most recently she sold 5,275 units of PACB stock worth $25,695 on 4 Mar 2024.
The largest trade she's ever made was exercising 22,496 units of PACB stock on 16 Feb 2024. As of 4 Mar 2024 she still owns at least 712,260 units of PACB stock.
Pacific Biosciences of California key executives
Pacific Biosciences of California, Inc. executives and other stock owners filed with the SEC:
- Dr. Denis Zaccarin Ph.D. (60) Senior Vice President of R&D
- Mr. Christian O. Henry M.B.A. (57) Pres, Chief Executive Officer & Director
- Ms. Susan G. Kim (48) Chief Financial Officer